PPARGC1A and coronary artery disorder: Changes were further confirmed by the decreased mRNA levels of UCP1 and PGC1α (Fig. 2e, f) and diminished UCP1, PGC1α, and Cidea protein expressions in CAD patients (Fig. 2c and d).